Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 0 | 2,998 | 837 | 889 | 1,040 |
| Gross Profit | N/A | 2,998 | 837 | 889 | 1,040 |
| Operating Expenses | 77,090 | 61,164 | 28,673 | 24,770 | 19,586 |
| Operating Income | -77,090 | -58,166 | -27,836 | -23,881 | -18,546 |
| Interest Expense | 400 | 11 | 8 | 6 | 6 |
| Other Income | 1,208 | 1,506 | 525 | 2,014 | 4,026 |
| Pre-tax Income | -76,282 | -56,671 | -27,319 | -21,873 | -14,526 |
| Net Income Continuous | -76,282 | -56,671 | -27,319 | -21,873 | -14,526 |
| Net Income | $-76,282 | $-56,671 | $-27,319 | $-21,873 | $-14,526 |
| EPS Basic Total Ops | -37.75 | -29.75 | -16.50 | -16.00 | -13.25 |
| EPS Basic Continuous Ops | -37.87 | -29.81 | -16.40 | -16.00 | -13.16 |
| EPS Diluted Total Ops | -37.75 | -29.75 | -16.50 | -16.00 | -13.25 |
| EPS Diluted Continuous Ops | -37.87 | -29.81 | -16.40 | -16.00 | -13.16 |
| EPS Diluted Before Non-Recurring Items | -37.75 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-69,271 | $-55,806 | $-27,095 | $-23,056 | $-17,995 |